JDD Special Focus

Acne Podcast Episodes

Stay up-to-date on new clinical findings on Acne. View the latest articles, case reports, editorial features, supplements, Podcast episodes and more!

 

Podcast Episodes

Ask the Investigator: Acne, OCPs, and a Side Order of Practical Pearls for the Adolescent Patient

 

JDD Podcast host Dr. Adam Friedman gets first-hand insight from internationally acclaimed pediatric dermatologist Dr. Lawrence Eichenfield on his recent study entitled “Hormonal Contraceptives and Acne: A Retrospective Analysis of 2147 Patients” published in the June 2016 edition of the Journal of Drugs of Dermatology. Want a refresher on the use of OCPs in Acne?

Interested in learning how to initiate a patient based survey study? Just curious how a leader in the field gets an uninterested adolescent to be compliant and engaged in his/her acne care? These are just a few of the practical pearls provided.

Sponsored

Featured Editorials

Virtual Exams No Substitute for In-Person Care of Acne and Rosacea

Some dermatologists may be surprised to hear that the concept of teledermatology originated 25 years ago, and has slowly increased in usage, primarily for the purpose of providing care to those in underserved areas.1 The challenges created by the COVID19 pandemic has rapidly accelerated both interest and usage of telemedicine by dermatologists, with the American Academy of Dermatology and other dedicated groups responding quickly to provide guidance on how to integrate teledermatology into real-world dermatology practice effectively, and hopefully with avoidance of technical, medicolegal, and financial pitfalls.2

 

Read Now

Sponsored

Featured Supplement

Androgens, Androgen Receptors, and the Skin

Of the four primary pathogenic factors that drive acne vulgaris—androgen excess, increased sebum production, faulty keratinization, and overgrowth of C. acnes—androgen excess has been the most elusive therapeutic target. Oral contraceptive pills (OCPs) have direct effect on circulating hormones, but their potential use is limited to a subset of women. As such, a sizable portion of the population affected by acne vulgaris cannot even consider treatment with OCPs. While these systemic agents are generally associated with a low risk profile and have a history of safe and effective use, they are not entirely risk-free. Indirect androgen modulation has become increasingly popular. Again, while generally safe and effective, this systemic treatment is not without risks and contraindications and it is also limited to a subset of female patients.

Read Now

Dermatology News

Featured ArticlesThe LatestVideo Abstract
December 29, 2025

Retrospective Review of Dermal Safety Studies of Organic Sunscreens

Check out our all-new JDD Video Abstract from Joshua Zeichner MD, who discusses Retrospective Review of Dermal Safety Studies of Organic Sunscreens.
Journal of Drugs in Dermatology JDD Article about Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial HyperpigmentationDyspigmentationFeatured ArticlesLatest News
December 25, 2025

Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation

Thiamidol shows rapid, sustained benefit for facial hyperpigmentation We’re highlighting a December 2025  article that we’re sure you’ll want to dive into! A 90‑patient randomized study found that thiamidol formulations…
JDD HighlightsJDD WebinarsThe LatestVideo Abstract
December 24, 2025

New Innovations of SkinCeuticals and Antioxidants Review

Join Dr. Jared Jagdeo, a board certified dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Jagdeo will present a review of the latest antioxidant science from SkinCeuticals. Faculty…
JDD HighlightsJDD WebinarsThe LatestVideo Abstract
December 24, 2025

Optimizing Patient Outcomes with Adjunctive OTC Skincare​

Join Dr. Ted Lain, Chief Medical Officer at Sanova Dermatology, and Star Walsh, R&D Director at Neutrogena®, for an informative webinar on the latest science and role of adjunctive OTC…